Component
Fulvic preparation in 2011 tau study, identity unresolved here
Context-specific entity; species, compartment and exposure are stated on each claim.
2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
The tested fulvic preparation reduced tau filament formation in vitro.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell-free tau aggregation and atomic-force microscopy.
- limitations
- Preparation identity and concentration are not resolved from the accessed abstract; no brain delivery or Alzheimer efficacy is demonstrated.
- nutrient_topic
- Fulvic acid collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Fulvic acid (heterogeneous humic fraction)
- plain_language
- One preparation interfered with fibril assembly.
- primary_references
- Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21785188/ · DOI 10.3233/JAD-2011-110623
Fulvic acid: mixture identity, mineral chemistry, signaling and cross-nutrient mechanisms (2026-09-19) · lines 148–154
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cell-free tau aggregation and atomic-force microscopy. · source_derived_draft · unverified_draft
## fulvic-acid-tau-assembly One preparation interfered with fibril assembly. The tested fulvic preparation reduced tau filament formation in vitro. Model: Cell-free tau aggregation and atomic-force microscopy. Limitations: Preparation identity and concentration are not resolved from the accessed abstract; no brain delivery or Alzheimer efficacy is demonstrated. Evidence access: Primary abstract Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21785188/ · DOI 10.3233/JAD-2011-110623
Complete structured claim and evidenceExposure altered preformed tau fibrils, including shorter filaments.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Cell-free atomic-force microscopy.
- limitations
- Proposed hydrophobic interaction is not a verified binding site; smaller structures need not be non-toxic.
- nutrient_topic
- Fulvic acid collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Fulvic acid (heterogeneous humic fraction)
- plain_language
- Already formed fibrils changed in the assay.
- primary_references
- Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21785188/ · DOI 10.3233/JAD-2011-110623
Fulvic acid: mixture identity, mineral chemistry, signaling and cross-nutrient mechanisms (2026-09-19) · lines 156–162
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Cell-free atomic-force microscopy. · source_derived_draft · unverified_draft
## fulvic-acid-tau-disassembly Already formed fibrils changed in the assay. Exposure altered preformed tau fibrils, including shorter filaments. Model: Cell-free atomic-force microscopy. Limitations: Proposed hydrophobic interaction is not a verified binding site; smaller structures need not be non-toxic. Evidence access: Primary abstract Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21785188/ · DOI 10.3233/JAD-2011-110623
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.